Dra. Narikazu Boku Oncología médica gastrointestinal

El Dr. Narikazu Boku es uno de los principales expertos en cáncer gastrointestinal en Tokio, Japón.

El Dr. Narikazu Boku es del departamento de Oncología Médica Gastrointestinal y es Director Adjunto del Hospital del Centro Nacional del Cáncer, Japón.

The division of Gastrointestinal Medical Oncology focuses on the development of new drugs and establishment of standard chemotherapy regimens including multimodality treatment with surgery and/or radiotherapy for advanced esophageal/gastric/colorectal cancers, gastrointestinal stromal tumor, and other gastrointestinal (GI) malignancies. The team does not only participate in many industry-sponsored trials but also conduct investigator-initiated trials, which are associated with translational research, in collaboration with many clinicians and basic researchers in Japan, Asia, and worldwide. Recently, the team has investigated biomarkers using pretreatment tumor and blood samples, including circulating tumor cell and cell-free DNA. Because easy access to tumor samples by endoscopy is a strong point in GI malignancy, the team is now preceding to translational research using repeated biopsy samples after administering investigational drugs.

Oncología médica gastrointestinal

• Oncología médica gastrointestinal
• Cáncer gastrointestinal
• Cáncer de Esófago
• Cáncer de estómago